Logo
x

Search

Subscribe Now

Type 2 Diabetes

Lilly Published Results of Tirzepatide in SURPASS-4 Study for the Treatment of Type 2 Diabetes in The Lancet

Lilly Published Results of Tirzepatide in SURPASS-4 Study for the Treatment of Type 2 Diabetes in The Lancet

  • October 19, 2021
Eli Lilly Reports Results of Tirzepatide in P-III SURPASS-3 MRI Sub-Study for the Treatment of Type 2 Diabetes

Eli Lilly Reports Results of Tirzepatide in P-III SURPASS-3 MRI Sub-Study for the Treatment of Type 2 Diabetes

  • September 30, 2021
Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Expanded Label Approval for the Treatment of Type 1 and Type 2 Diabetes

Eli Lilly's Lyumjev (insulin lispro-aabc injection) Receives the US FDA's Expanded Label Approval for the Treatment of Type 1 and...

  • August 17, 2021
Bayer's Kerendia (finerenone) Receives the US FDA's Approval for the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes

Bayer's Kerendia (finerenone) Receives the US FDA's Approval for the Treatment of Chronic Kidney Disease Associated with Type 2 Di...

  • July 12, 2021
Sanofi Reports Results of Soliqua (insulin glargine and lixisenatide) in SoliMix Study for the Treatment of Type 2 Diabetes

Sanofi Reports Results of Soliqua (insulin glargine and lixisenatide) in SoliMix Study for the Treatment of Type 2 Diabetes

  • June 29, 2021
Lilly Reports Results of Tirzepatide in SURPASS-4 Study for Patients with Type 2 Diabetes

Lilly Reports Results of Tirzepatide in SURPASS-4 Study for Patients with Type 2 Diabetes

  • May 20, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.